-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

625.Oral2.6 625. Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
apoptosis, Diseases, Therapies, Mechanisms, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Clinically relevant, Lymphoid Malignancies, T-Cell Lymphoma, immune mechanism, signal transduction
Saturday, December 9, 2017: 9:30 AM-11:00 AM
Bldg C, Lvl 1, C101 Aud (Georgia World Congress Center)
Moderators:
Sascha Dietrich, MD, University of Heidleberg and Samuel Y. Ng, MD, PhD, Dana-Farber Cancer Institute
Disclosures:
No relevant conflicts of interest to declare.
9:30 AM

Danilo Fiore, PhD1*, Xujun Wang1*, Inna Khodos2*, Filomena Di Giacomo, PhD1*, Marcello Gaudiano, BS1*, Jude M Phillip, DPhil3*, Rui Wang1*, Zhiwei Yang1*, Michael Ginsberg4*, Andrew M Intlekofer, MD, PhD5,6, Craig B. Thompson, MD7, Jon C. Aster, MD, PhD8, Jia Ruan, MD, PhD9, Samuel Y. Ng, MD, PhD10, Eric Jacobsen, MD11, Ahmet Dogan, MD, PhD7, Elisa de Stanchina12*, Marissa Mattar2*, Leandro Cerchietti, MD13, Rohan Bareja14*, Olivier Elemento, PhD15*, Wayne Tam, MD, PhD16, David M. Weinstock, MD11, Shahin Rafii, MD17*, Steven M. Horwitz, MD18 and Giorgio Inghirami, MD1*

1Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
2Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Weill Cornell Medicine, New York, NY
4Angiocrine Bioscience, San Diego, CA
5Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY
6Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY
7Memorial Sloan Kettering Cancer Center, New York, NY
8Brigham and Women's Hosp., Boston, MA
9New York Presbyterian Hospital (Cornell Campus), New York, NY
10Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
11Dana-Farber Cancer Institute, Boston, MA
12Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center,, New York, NY
13Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medical College, New York, NY
14Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY
15Caryl and Israel Englander Institute for Precision Medicine, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY
16Department of Pathology and Laboratory Medicine, Well Cornell Medical College, New York, NY
17Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY
18Department of Medical Oncology, Memorial Sloan-Kettering Cancer Ctr., New York, NY

9:45 AM

Sneha Purvey, MD1, Ravi Dashnamoorthy, PhD2, Afshin Beheshti, PhD3, Andreas Klein, MD4, Laurent Boissel, PhD5*, Saheli Sarkar, PhD6*, Tali Konry, PhD7* and Andrew M. Evens, DO, MSc8

1Department of Hematology and Oncology, Tufts Medical Center, Boston, MA
2Molecular Oncology Research Institute, Tufts Medical Center, Shrewsbury, MA
3Molecular Oncology Research Institute, Boston, MA
4Tufts Medical Center, Boston, MA
5NantKwest, Inc., Woburn, MA
6Department of Pharmaceutical Sciences, Northeastern Universtity, Boston, MA
7Department of Pharmaceutical Sciences, Northeastern University, Boston, MA
8Tufts University School of Medicine and Cancer Center, Boston, MA

10:00 AM

Moritz Bewarder, MD1*, Lorenz Thurner, MD2*, Klaus Dieter Preuss, PhD3*, Evi Regitz3*, Natalie Fadle3* and Michael Pfreundschuh, MD 2

1Department for hematology and oncology, Saarland University Medical School, Homburg, Saarland, Germany
2Department for hematology and oncology, Saarland University Medical School, Homburg, Germany
3José-Carreras-Center, Dept. Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany

10:15 AM

Steven E Kauder, PhD*, Tracy C Kuo, PhD*, Amy Chen*, Ons Harrabi*, Sony S Rocha*, Laura Doyle*, Sangeetha Bollini*, Bora Han, PhD*, Emma Ruth B Sangalang*, Janet Sim, PhD*, Sophia Randolph, MD, PhD, Jaume Pons, PhD* and Hong I Wan, PhD*

Alexo Therapeutics, South San Francisco, CA

10:30 AM

Idit Sagiv Barfi, PhD1*, Debra K. Czerwinski, BA2 and Ronald Levy, MD3

1Stanford University, Palo Alto, CA
2Stanford University Medical Center, Stanford, CA
3Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA

10:45 AM

Cody Ramirez, BS1, Kilannin Krysiak, PhD1,2*, Felicia Gomez, PhD3*, Susanna Kiwala1*, Christopher A. Miller, PhD1,2*, Katie Campbell1*, Jasreet Hundal1*, Jason Walker1*, Malachi Griffith, PhD1,2,4,5*, Obi Griffith1,2,4,5* and Todd A. Fehniger, MD, PhD5,6

1McDonnell Genome Institute, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
2Department of Medicine, Washington University School of Medicine, Saint Louis, MO
3McDonnell Genome Institute, Department of Medicine, Washington University School of Medicine, St Louis, MO
4Department of Genetics, Washington University School of Medicine, Saint Louis, MO
5Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
6Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO

*signifies non-member of ASH